Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02624700
Title Study of Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Virginia Commonwealth University
Age Groups: adult
Covered Countries USA

No variant requirements are available.